Autophagy, innate immunity and tissue repair in acute kidney injury

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Duann, Pu ^a,b   Lianos, Elias A ^c,d   Ma, Jianjie ^a,b   Lin, Pei Hui ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Ischemia reperfusion injury; Kidney disease; Nephrotoxicity; Oxidative stress; Tissue regeneration

Indexed keywords

CASPASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ACUTE KIDNEY FAILURE; AUTOPHAGY; CELL DEATH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LYSOPHAGY; MITOCHONDRIAL DYNAMICS; MITOPHAGY; NECROSIS; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR; ACUTE KIDNEY INJURY; ANIMAL; APOPTOSIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; REGENERATION;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; AUTOPHAGY; HUMANS; IMMUNITY, INNATE; REGENERATION;

EID: 84965026127     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050662     Document Type: Review

References (129)

1. Lameire, N. H.; Bagga, A.; Cruz, D.; de Maeseneer, J.; Endre, Z.; Kellum, J. A.; Liu, K. D.; Mehta, R. L.; Pannu, N.; van Biesen, W.; et al. Acute kidney injury: An increasing global concern. Lancet 2013, 382, 170-179. [CrossRef]
2. Susantitaphong, P.; Cruz, D. N.; Cerda, J.; Abulfaraj, M.; Alqahtani, F.; Koulouridis, I.; Jaber, B. L. World incidence of AKI: A meta-analysis. Clin. J. Am. Soc. Nephrol. 2013, 8, 1482-1493. [CrossRef] [PubMed]
3. Mehta, R. L.; Cerda, J.; Burdmann, E. A.; Tonelli, M.; Garcia-Garcia, G.; Jha, V.; Susantitaphong, P.; Rocco, M.; Vanholder, R.; Sever, M. S.; et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology. Lancet 2015, 385, 2616-2643. [CrossRef]
4. Bellomo, R.; Kellum, J. A.; Ronco, C. Acute kidney injury. Lancet 2012, 380, 756-766. [CrossRef]
5. Rewa, O.; Bagshaw, S. M. Acute kidney injury-epidemiology, outcomes and economics. Nat. Rev. Nephrol. 2014, 10, 193-207. [CrossRef] [PubMed]
6. Yang, L.; Xing, G.; Wang, L.; Wu, Y.; Li, S.; Xu, G.; He, Q.; Chen, J.; Chen, M.; Liu, X.; et al. Acute kidney injury in China: A cross-sectional survey. Lancet 2015, 386, 1465-1471. [CrossRef]
7. Silver, S. A.; Cardinal, H.; Colwell, K.; Burger, D.; Dickhout, J. G. Acute kidney injury: Preclinical innovations, challenges, and opportunities for translation. Can. J. Kidney Health Dis. 2015, 2. [CrossRef] [PubMed]
8. Kdigo, A. K. I. Kidney Disease Improving Global Outcomes. AKI Work Group: Clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2012, 2, 1-138.
9. Sancho-Martinez, S. M.; Lopez-Novoa, J. M.; Lopez-Hernandez, F. J. Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clin. Kidney J. 2015, 8, 548-559. [CrossRef] [PubMed]
10. Hoenig, M. P.; Zeidel, M. L. Homeostasis, the milieu interieur, and the wisdom of the nephron. Clin. J. Am. Soc. Nephrol. 2014, 9, 1272-1281. [CrossRef] [PubMed]
11. Hall, A. M.; Unwin, R. J.; Parker, N.; Duchen, M. R. Multiphoton imaging reveals differences in mitochondrial function between nephron segments. J. Am. Soc. Nephrol. 2009, 20, 1293-1302. [CrossRef] [PubMed]
12. Bonventre, J. V.; Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Investig. 2011, 121, 4210-4221. [CrossRef] [PubMed]
13. Zuk, A.; Bonventre, J. V. Acute Kidney Injury. Annu. Rev. Med. 2016, 67, 293-307. [CrossRef] [PubMed]
14. Heyman, S. N.; Rosenberger, C.; Rosen, S. Acute kidney injury: Lessons from experimental models. Contrib. Nephrol. 2011, 169, 286-296. [PubMed]
15. Ueno, K.; Sato, H. Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs. Hypertens. Res. 2012, 35, 245-250. [CrossRef] [PubMed]
16. Joseph, S.; Nicolson, T. J.; Hammons, G.; Word, B.; Green-Knox, B.; Lyn-Cook, B. Expression of drug transporters in human kidney: Impact of sex, age, and ethnicity. Biol. Sex Differ. 2015, 6, 4. [CrossRef] [PubMed]
17. Breljak, D.; Brzica, H.; Sweet, D. H.; Anzai, N.; Sabolic, I. Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys. Am. J. Physiol. Ren. Physiol. 2013, 304, F1114-F1126. [CrossRef] [PubMed]
18. Bagshaw, S. M.; Langenberg, C.; Wan, L.; May, C. N.; Bellomo, R. A systematic review of urinary findings in experimental septic acute renal failure. Crit. Care Med. 2007, 35, 1592-1598. [CrossRef] [PubMed]
19. Singh, A. P.; Junemann, A.; Muthuraman, A.; Jaggi, A. S.; Singh, N.; Grover, K.; Dhawan, R. Animal models of acute renal failure. Pharmacol. Rep. 2012, 64, 31-44. [CrossRef]
20. Ortiz, A.; Sanchez-Nino, M. D.; Izquierdo, M. C.; Martin-Cleary, C.; Garcia-Bermejo, L.; Moreno, J. A.; Ruiz-Ortega, M.; Draibe, J.; Cruzado, J. M.; Garcia-Gonzalez, M. A.; et al. Translational value of animal models of kidney failure. Eur. J. Pharmacol. 2015, 759, 205-220. [CrossRef] [PubMed]
21. Sander, V.; Davidson, A. J. Kidney injury and regeneration in zebrafish. Semin. Nephrol. 2014, 34, 437-444. [CrossRef] [PubMed]
22. McKee, R. A.; Wingert, R. A. Zebrafish renal pathology: Emerging models of acute kidney injury. Curr. Pathobiol. Rep. 2015, 3, 171-181. [CrossRef] [PubMed]
23. Morizane, R.; Lam, A. Q.; Freedman, B. S.; Kishi, S.; Valerius, M. T.; Bonventre, J. V. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 2015, 33, 1193-1200. [CrossRef] [PubMed]
24. Sander, J. D.; Joung, J. K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014, 32, 347-355. [CrossRef] [PubMed]
25. Trevino, A. E.; Zhang, F. Genome editing using Cas9 nickases. Methods Enzymol. 2014, 546, 161-174. [PubMed]
26. Freedman, B. S.; Brooks, C. R.; Lam, A. Q.; Fu, H.; Morizane, R.; Agrawal, V.; Saad, A. F.; Li, M. K.; Hughes, M. R.; Werff, R. V.; et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun. 2015, 6, 8715. [CrossRef] [PubMed]
27. Togel, F.; Westenfelder, C. Recent advances in the understanding of acute kidney injury. F1000Prime Rep. 2014, 6. [CrossRef] [PubMed]
28. Chawla, L. S.; Kimmel, P. L. Acute kidney injury and chronic kidney disease: An integrated clinical syndrome. Kidney Int. 2012, 82, 516-524. [CrossRef] [PubMed]
29. Belayev, L. Y.; Palevsky, P. M. The link between acute kidney injury and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2014, 23, 149-154. [CrossRef] [PubMed]
30. Venkatachalam, M. A.; Weinberg, J. M.; Kriz, W.; Bidani, A. K. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J. Am. Soc. Nephrol. 2015, 26, 1765-1776. [CrossRef] [PubMed]
31. Wang, X.; Bonventre, J. V.; Parrish, A. R. The aging kidney: Increased susceptibility to nephrotoxicity. Int. J. Mol. Sci. 2014, 15, 15358-15376. [CrossRef] [PubMed]
32. Linkermann, A.; Chen, G.; Dong, G.; Kunzendorf, U.; Krautwald, S.; Dong, Z. Regulated cell death in AKI. J. Am. Soc. Nephrol. 2014, 25, 2689-2701. [CrossRef] [PubMed]
33. Kurts, C.; Panzer, U.; Anders, H. J.; Rees, A. J. The immune system and kidney disease: Basic concepts and clinical implications. Nat. Rev. Immunol. 2013, 13, 738-753. [CrossRef] [PubMed]
34. Anders, H. J.; Schaefer, L. Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J. Am. Soc. Nephrol. 2014, 25, 1387-1400. [CrossRef] [PubMed]
35. Zhan, M.; Brooks, C.; Liu, F.; Sun, L.; Dong, Z. Mitochondrial dynamics: Regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int. 2013, 83, 568-581. [CrossRef] [PubMed]
36. Stallons, L. J.; Funk, J. A.; Schnellmann, R. G. Mitochondrial homeostasis in acute organ failure. Curr. Pathobiol. Rep. 2013, 1, 169-177. [CrossRef] [PubMed]
37. Brooks, C.; Wei, Q.; Cho, S. G.; Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Investig. 2009, 119, 1275-1285. [CrossRef] [PubMed]
38. Drose, S.; Brandt, U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv. Exp. Med. Biol. 2012, 748, 145-169. [PubMed]
39. Che, R.; Yuan, Y.; Huang, S.; Zhang, A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am. J. Physiol. Ren. Physiol. 2014, 306, F367-F378. [CrossRef] [PubMed]
40. Putti, R.; Sica, R.; Migliaccio, V.; Lionetti, L. Diet impact on mitochondrial bioenergetics and dynamics. Front. Physiol. 2015, 6. [CrossRef] [PubMed]
41. Eisner, V.; Lenaers, G.; Hajnoczky, G. Mitochondrial fusion is frequent in skeletal muscle and supports excitation-contraction coupling. J. Cell Biol. 2014, 205, 179-195. [CrossRef] [PubMed]
42. Liu, R.; Jin, P.; Yu, L.; Wang, Y.; Han, L.; Shi, T.; Li, X. Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle. PLoS ONE 2014, 9, e92810. [CrossRef] [PubMed]
43. Qi, X.; Qvit, N.; Su, Y. C.; Mochly-Rosen, D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 2013, 126 Pt 3, 789-802. [CrossRef] [PubMed]
44. Loson, O. C.; Song, Z.; Chen, H.; Chan, D. C. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol. Biol. Cell 2013, 24, 659-667. [CrossRef] [PubMed]
45. Frezza, C.; Cipolat, S.; Martins de Brito, O.; Micaroni, M.; Beznoussenko, G. V.; Rudka, T.; Bartoli, D.; Polishuck, R. S.; Danial, N. N.; de Strooper, B.; et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126, 177-189. [CrossRef] [PubMed]
46. Palmer, C. S.; Osellame, L. D.; Stojanovski, D.; Ryan, M. T. The regulation of mitochondrial morphology: Intricate mechanisms and dynamic machinery. Cell Signal. 2011, 23, 1534-1545. [CrossRef] [PubMed]
47. Weinberg, J. M. Mitochondrial biogenesis in kidney disease. J. Am. Soc. Nephrol. 2011, 22, 431-446. [CrossRef] [PubMed]
48. Funk, J. A.; Schnellmann, R. G. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am. J. Physiol. Ren. Physiol. 2012, 302, F853-F864. [CrossRef] [PubMed]
49. Disatnik, M. H.; Ferreira, J. C.; Campos, J. C.; Gomes, K. S.; Dourado, P. M.; Qi, X.; Mochly-Rosen, D. Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J. Am. Heart Assoc. 2013, 2, e000461. [CrossRef] [PubMed]
50. Morigi, M.; Perico, L.; Rota, C.; Longaretti, L.; Conti, S.; Rottoli, D.; Novelli, R.; Remuzzi, G.; Benigni, A. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J. Clin. Investig. 2015, 125, 715-726. [CrossRef] [PubMed]
51. Hall, A. M.; Molitoris, B. A. Dynamic multiphoton microscopy: Focusing light on acute kidney injury. Physiology (Bethesda) 2014, 29, 334-342. [CrossRef] [PubMed]
52. Hall, A. M.; Rhodes, G. J.; Sandoval, R. M.; Corridon, P. R.; Molitoris, B. A. In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury. Kidney Int. 2013, 83, 72-83. [CrossRef] [PubMed]
53. Hall, A. M.; Crawford, C.; Unwin, R. J.; Duchen, M. R.; Peppiatt-Wildman, C. M. Multiphoton imaging of the functioning kidney. J. Am. Soc. Nephrol. 2011, 22, 1297-1304. [CrossRef] [PubMed]
54. Valles, P. G.; Lorenzo, A. G.; Bocanegra, V.; Valles, R. Acute kidney injury: What part do Toll-like receptors play? Int. J. Nephrol. Renovasc. Dis. 2014, 7, 241-251. [CrossRef] [PubMed]
55. Leemans, J. C.; Stokman, G.; Claessen, N.; Rouschop, K. M.; Teske, G. J.; Kirschning, C. J.; Akira, S.; van der Poll, T.; Weening, J. J.; Florquin, S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Investig. 2005, 115, 2894-2903. [CrossRef] [PubMed]
56. Mudaliar, H.; Pollock, C.; Komala, M. G.; Chadban, S.; Wu, H.; Panchapakesan, U. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am. J. Physiol. Ren. Physiol. 2013, 305, F143-F154. [CrossRef] [PubMed]
57. Shahzad, K.; Bock, F.; Dong, W.; Wang, H.; Kopf, S.; Kohli, S.; Al-Dabet, M. M.; Ranjan, S.; Wolter, J.; Wacker, C.; et al. NLRP3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015, 87, 74-84. [CrossRef] [PubMed]
58. Munoz-Planillo, R.; Kuffa, P.; Martinez-Colon, G.; Smith, B. L.; Rajendiran, T. M.; Nunez, G. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013, 38, 1142-1153. [CrossRef] [PubMed]
59. Deplano, S.; Cook, H. T.; Russell, R.; Franchi, L.; Schneiter, S.; Bhangal, G.; Unwin, R. J.; Pusey, C. D.; Tam, F. W.; Behmoaras, J. P2X7 receptor-mediated NLRP3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis. J. Leukoc. Biol. 2013, 93, 127-134. [CrossRef] [PubMed]
60. Decuypere, J. P.; Pirenne, J.; Jochmans, I. Autophagy in renal ischemia-reperfusion injury: Friend or foe? Am. J. Transplant. 2014, 14, 1464-1465. [CrossRef] [PubMed]
61. Hornung, V.; Latz, E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010, 40, 620-623. [CrossRef] [PubMed]
62. Okada, M.; Matsuzawa, A.; Yoshimura, A.; Ichijo, H. The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J. Biol. Chem. 2014, 289, 32926-32936. [CrossRef] [PubMed]
63. Hauenstein, A. V.; Zhang, L.; Wu, H. The hierarchical structural architecture of inflammasomes, supramolecular inflammatory machines. Curr. Opin. Struct. Biol. 2015, 31, 75-83. [CrossRef] [PubMed]
64. Zhuang, Y.; Hu, C.; Ding, G.; Zhang, Y.; Huang, S.; Jia, Z.; Zhang, A. Albumin impairs renal tubular tight junctions via targeting the NLRP3 inflammasome. Am. J. Physiol. Ren. Physiol. 2015, 308, F1012-F1019. [CrossRef] [PubMed]
65. De Zoete, M. R.; Palm, N. W.; Zhu, S.; Flavell, R. A. Inflammasomes. Cold Spring Harb. Perspect. Biol. 2014, 6, a016287. [CrossRef] [PubMed]
66. Darisipudi, M. N.; Knauf, F. An update on the role of the inflammasomes in the pathogenesis of kidney diseases. Pediatr. Nephrol. 2015, 31, 535-544. [CrossRef] [PubMed]
67. Leemans, J. C.; Kors, L.; Anders, H. J.; Florquin, S. Pattern recognition receptors and the inflammasome in kidney disease. Nat. Rev. Nephrol. 2014, 10, 398-414. [CrossRef] [PubMed]
68. Hagemann, J. H.; Haegele, H.; Muller, S.; Anders, H. J. Danger control programs cause tissue injury and remodeling. Int. J. Mol. Sci. 2013, 14, 11319-11346. [CrossRef] [PubMed]
69. Lech, M.; Grobmayr, R.; Ryu, M.; Lorenz, G.; Hartter, I.; Mulay, S. R.; Susanti, H. E.; Kobayashi, K. S.; Flavell, R. A.; Anders, H. J. Macrophage phenotype controls long-term AKI outcomes-Kidney regeneration versus atrophy. J. Am. Soc. Nephrol. 2014, 25, 292-304. [CrossRef] [PubMed]
70. Yoshida, M.; Honma, S. Regeneration of injured renal tubules. J. Pharmacol. Sci. 2014, 124, 117-122. [CrossRef] [PubMed]
71. Kusaba, T.; Humphreys, B. D. Controversies on the origin of proliferating epithelial cells after kidney injury. Pediatr. Nephrol. 2014, 29, 673-679. [CrossRef] [PubMed]
72. Camussi, G.; Deregibus, M. C.; Tetta, C. Paracrine/endocrine mechanism of stem cells on kidney repair: Role of microvesicle-mediated transfer of genetic information. Curr. Opin. Nephrol. Hypertens. 2010, 19, 7-12. [CrossRef] [PubMed]
73. Sabin, K.; Kikyo, N. Microvesicles as mediators of tissue regeneration. Transl. Res. 2014, 163, 286-295. [CrossRef] [PubMed]
74. Yang, L.; Humphreys, B. D.; Bonventre, J. V. Pathophysiology of acute kidney injury to chronic kidney disease: Maladaptive repair. Contrib. Nephrol. 2011, 174, 149-155. [PubMed]
75. Barnes, J. L.; Glass, W. F., 2nd. Renal interstitial fibrosis: A critical evaluation of the origin of myofibroblasts. Contrib. Nephrol. 2011, 169, 73-93. [PubMed]
76. Chuang, P. Y.; Menon, M. C.; He, J. C. Molecular targets for treatment of kidney fibrosis. J. Mol. Med. (Berl.) 2013, 91, 549-559. [CrossRef] [PubMed]
77. Duffield, J. S. Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Investig. 2014, 124, 2299-2306. [PubMed]
78. Wu, X.; Won, H.; Rubinsztein, D. C. Autophagy and mammalian development. Biochem. Soc. Trans. 2013, 41, 1489-1494. [PubMed]
79. Paulus, G. L.; Xavier, R. J. Autophagy and checkpoints for intracellular pathogen defense. Curr. Opin. Gastroenterol. 2015, 31, 14-23. [PubMed]
80. Steele, S.; Brunton, J.; Kawula, T. The role of autophagy in intracellular pathogen nutrient acquisition. Front. Cell. Infect. Microbiol. 2015, 5, 51. [PubMed]
81. Anding, A. L.; Baehrecke, E. H. Autophagy in Cell Life and Cell Death. Curr. Top. Dev. Biol. 2015, 114, 67-91. [PubMed]
82. Wesselborg, S.; Stork, B. Autophagy signal transduction by ATG proteins: From hierarchies to networks. Cell. Mol. Life Sci. 2015, 72, 4721-4757. [CrossRef] [PubMed]
83. Tanida, I. Autophagosome formation and molecular mechanism of autophagy. Antioxid. Redox Signal. 2011, 14, 2201-2214. [CrossRef] [PubMed]
84. Chittaranjan, S.; Bortnik, S.; Gorski, S. M. Monitoring Autophagic Flux by Using Lysosomal Inhibitors and Western Blotting of Endogenous MAP1LC3B. Cold Spring Harb. Protoc. 2015, 2015, 743-750. [CrossRef] [PubMed]
85. Esteban-Martinez, L.; Boya, P. Autophagic flux determination in vivo and ex vivo. Methods 2015, 75, 79-86. [CrossRef] [PubMed]
86. Gottlieb, R. A.; Andres, A. M.; Sin, J.; Taylor, D. P. Untangling autophagy measurements: All fluxed up. Circ. Res. 2015, 116, 504-514. [CrossRef] [PubMed]
87. Jiang, P.; Mizushima, N. Autophagy and human diseases. Cell Res. 2014, 24, 69-79. [CrossRef] [PubMed]
88. Wang, Y.; Nartiss, Y.; Steipe, B.; McQuibban, G. A.; Kim, P. K. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy 2012, 8, 1462-1476. [CrossRef] [PubMed]
89. Li, L.; Wang, Z. V.; Hill, J. A.; Lin, F. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J. Am. Soc. Nephrol. 2014, 25, 305-315. [CrossRef] [PubMed]
90. Suzuki, C.; Isaka, Y.; Takabatake, Y.; Tanaka, H.; Koike, M.; Shibata, M.; Uchiyama, Y.; Takahara, S.; Imai, E. Participation of autophagy in renal ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 2008, 368, 100-106. [CrossRef] [PubMed]
91. Jiang, M.; Liu, K.; Luo, J.; Dong, Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am. J. Pathol. 2010, 176, 1181-1192. [CrossRef] [PubMed]
92. Takahashi, A.; Kimura, T.; Takabatake, Y.; Namba, T.; Kaimori, J.; Kitamura, H.; Matsui, I.; Niimura, F.; Matsusaka, T.; Fujita, N.; et al. Autophagy guards against cisplatin-induced acute kidney injury. Am. J. Pathol. 2012, 180, 517-525. [CrossRef] [PubMed]
93. Liu, S.; Hartleben, B.; Kretz, O.; Wiech, T.; Igarashi, P.; Mizushima, N.; Walz, G.; Huber, T. B. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy 2012, 8, 826-837. [CrossRef] [PubMed]
94. Jiang, M.; Wei, Q.; Dong, G.; Komatsu, M.; Su, Y.; Dong, Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int. 2012, 82, 1271-1283. [CrossRef] [PubMed]
95. Kimura, T.; Takabatake, Y.; Takahashi, A.; Kaimori, J. Y.; Matsui, I.; Namba, T.; Kitamura, H.; Niimura, F.; Matsusaka, T.; Soga, T.; et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 2011, 22, 902-913. [CrossRef] [PubMed]
96. Li, J.; Xu, Z.; Jiang, L.; Mao, J.; Zeng, Z.; Fang, L.; He, W.; Yuan, W.; Yang, J.; Dai, C. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury. Kidney Int. 2014, 86, 86-102. [CrossRef] [PubMed]
97. Grahammer, F.; Haenisch, N.; Steinhardt, F.; Sander, L.; Roerden, M.; Arnold, F.; Cordts, T.; Wanner, N.; Reichardt, W.; Kerjaschki, D.; et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc. Natl. Acad. Sci. USA 2014, 111, E2817-E2826. [CrossRef] [PubMed]
98. Hsiao, H. W.; Tsai, K. L.; Wang, L. F.; Chen, Y. H.; Chiang, P. C.; Chuang, S. M.; Hsu, C. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 2012, 37, 289-296. [CrossRef] [PubMed]
99. Zhang, X.; Howell, G. M.; Guo, L.; Collage, R. D.; Loughran, P. A.; Zuckerbraun, B. S.; Rosengart, M. R. CaMKIV-dependent preservation of mTOR expression is required for autophagy during lipopolysaccharide-induced inflammation and acute kidney injury. J. Immunol. 2014, 193, 2405-2415. [CrossRef] [PubMed]
100. Howell, G. M.; Gomez, H.; Collage, R. D.; Loughran, P.; Zhang, X.; Escobar, D. A.; Billiar, T. R.; Zuckerbraun, B. S.; Rosengart, M. R. Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS ONE 2013, 8, e69520. [CrossRef] [PubMed]
101. Decuypere, J. P.; Ceulemans, L. J.; Agostinis, P.; Monbaliu, D.; Naesens, M.; Pirenne, J.; Jochmans, I. Autophagy and the kidney: Implications for ischemia-reperfusion injury and therapy. Am. J. Kidney Dis. 2015, 66, 699-709. [CrossRef] [PubMed]
102. Wang, Z.; Choi, M. E. Autophagy in kidney health and disease. Antioxid. Redox Signal. 2014, 20, 519-537. [CrossRef] [PubMed]
103. Okamoto, K. Organellophagy: Eliminating cellular building blocks via selective autophagy. J. Cell Biol. 2014, 205, 435-445. [CrossRef] [PubMed]
104. Hung, Y. H.; Chen, L. M.; Yang, J. Y.; Yang, W. Y. Spatiotemporally controlled induction of autophagy-mediated lysosome turnover. Nat. Commun. 2013, 4, 2111. [CrossRef] [PubMed]
105. Parikh, S. M.; Yang, Y.; He, L.; Tang, C.; Zhan, M.; Dong, Z. Mitochondrial function and disturbances in the septic kidney. Semin. Nephrol. 2015, 35, 108-119. [CrossRef] [PubMed]
106. Durcan, T. M.; Fon, E. A. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 2015, 29, 989-999. [CrossRef] [PubMed]
107. Bingol, B.; Tea, J. S.; Phu, L.; Reichelt, M.; Bakalarski, C. E.; Song, Q.; Foreman, O.; Kirkpatrick, D. S.; Sheng, M. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 2014, 510, 370-375.
108. Cunningham, C. N.; Baughman, J. M.; Phu, L.; Tea, J. S.; Yu, C.; Coons, M.; Kirkpatrick, D. S.; Bingol, B.; Corn, J. E. USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 2015, 17, 160-169.
109. Ney, P. A. Normal and disordered reticulocyte maturation. Curr. Opin. Hematol. 2011, 18, 152-157.
110. Zhang, H.; Bosch-Marce, M.; Shimoda, L. A.; Tan, Y. S.; Baek, J. H.; Wesley, J. B.; Gonzalez, F. J.; Semenza, G. L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283, 10892-10903.
111. Youle, R. J.; Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12, 9-14.
112. Wei, Q.; Dong, G.; Chen, J. K.; Ramesh, G.; Dong, Z. Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney Int. 2013, 84, 138-148.
113. Maejima, I.; Takahashi, A.; Omori, H.; Kimura, T.; Takabatake, Y.; Saitoh, T.; Yamamoto, A.; Hamasaki, M.; Noda, T.; Isaka, Y.; et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 2013, 32, 2336-2347.
114. Christensen, E. I.; Verroust, P. J.; Nielsen, R. Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch. 2009, 458, 1039-1048. [CrossRef] [PubMed]
115. Lee, D.; Gleich, K.; Fraser, S. A.; Katerelos, M.; Mount, P. F.; Power, D. A. Limited capacity of proximal tubular proteolysis in mice with proteinuria. Am. J. Physiol. Ren. Physiol. 2013, 304, F1009-F1019. [CrossRef] [PubMed]
116. Pourahmad, J.; Hosseini, M. J.; Eskandari, M. R.; Shekarabi, S. M.; Daraei, B. Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity. Xenobiotica 2010, 40, 763-771. [CrossRef] [PubMed]
117. Guo, R.; Wang, Y.; Minto, A. W.; Quigg, R. J.; Cunningham, P. N. Acute renal failure in endotoxemia is dependent on caspase activation. J. Am. Soc. Nephrol. 2004, 15, 3093-3102. [CrossRef] [PubMed]
118. Mulay, S. R.; Linkermann, A.; Anders, H. J. Necroinflammation in kidney disease. J. Am. Soc. Nephrol. 2015, 27, 27-39. [CrossRef] [PubMed]
119. Liang, X.; Chen, Y.; Zhang, L.; Jiang, F.; Wang, W.; Ye, Z.; Liu, S.; Yu, C.; Shi, W. Necroptosis, a novel form of caspase-independent cell death, contributes to renal epithelial cell damage in an ATP-depleted renal ischemia model. Mol. Med. Rep. 2014, 10, 719-724. [CrossRef] [PubMed]
120. Patschan, D.; Patschan, S.; Muller, G. A. Endothelial progenitor cells in acute ischemic kidney injury: Strategies for increasing the cells' renoprotective competence. Int. J. Nephrol. 2011, 2011, 828369. [CrossRef] [PubMed]
121. Xing, L.; Cui, R.; Peng, L.; Ma, J.; Chen, X.; Xie, R. J.; Li, B. Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury. Stem Cell Res. Ther. 2014, 5, 101. [CrossRef] [PubMed]
122. Lorenzen, J. M. Vascular and circulating microRNAs in renal ischaemia-reperfusion injury. J. Physiol. 2015, 593, 1777-1784. [CrossRef] [PubMed]
123. Zarjou, A.; Kim, J.; Traylor, A. M.; Sanders, P. W.; Balla, J.; Agarwal, A.; Curtis, L. M. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am. J. Physiol. Ren. Physiol. 2011, 300, F254-F262. [CrossRef] [PubMed]
124. Sumida, M.; Doi, K.; Ogasawara, E.; Yamashita, T.; Hamasaki, Y.; Kariya, T.; Takimoto, E.; Yahagi, N.; Nangaku, M.; Noiri, E. Regulation of mitochondrial dynamics by dynamin-related protein-1 in acute cardiorenal syndrome. J. Am. Soc. Nephrol. 2015, 26, 2378-2387. [CrossRef] [PubMed]
125. Tang, W. X.; Wu, W. H.; Qiu, H. Y.; Bo, H.; Huang, S. M. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of DRP-1 translocation. J. Nephrol. 2013, 26, 1073-1082. [CrossRef] [PubMed]
126. Chen, B. L.; Wang, L. T.; Huang, K. H.; Wang, C. C.; Chiang, C. K.; Liu, S. H. Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway. J. Nutr. Biochem. 2014, 25, 1226-1234. [CrossRef] [PubMed]
127. Berry, M.; Clatworthy, M. R. Immunotherapy for acute kidney injury. Immunotherapy 2012, 4, 323-334. [CrossRef] [PubMed]
128. Rodrigo, E.; Minambres, E.; Ruiz, J. C.; Ballesteros, A.; Pinera, C.; Quintanar, J.; Fernandez-Fresnedo, G.; Palomar, R.; Gomez-Alamillo, C.; Arias, M. Prediction of delayed graft function by means of a novel web-based calculator: A single-center experience. Am. J. Transplant. 2012, 12, 240-244. [CrossRef] [PubMed]
129. Chapal, M.; Le Borgne, F.; Legendre, C.; Kreis, H.; Mourad, G.; Garrigue, V.; Morelon, E.; Buron, F.; Rostaing, L.; Kamar, N.; et al. A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors. Kidney Int. 2014, 86, 1130-1139. [CrossRef] [PubMed]